alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS OF USCS INTERNATIONAL, INC. AS OF
JUNE 30, 1997 FOR THE SIX MONTHS THEN ENDED AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               JUN-30-1997
<CASH>                                           8,641
<SECURITIES>                                         0
<RECEIVABLES>                                   71,445
<ALLOWANCES>                                         0
<INVENTORY>                                      4,083
<CURRENT-ASSETS>                                94,989
<PP&E>                                         181,757
<DEPRECIATION>                                  86,877
<TOTAL-ASSETS>                                 202,697
<CURRENT-LIABILITIES>                           46,691
<BONDS>                                          3,048<F1>
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         1,162
<OTHER-SE>                                     126,426<F2>
<TOTAL-LIABILITY-AND-EQUITY>                   202,697
<SALES>                                              0
<TOTAL-REVENUES>                               143,668
<CGS>                                                0
<TOTAL-COSTS>                                   83,361
<OTHER-EXPENSES>                                42,193<F3>
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 355
<INCOME-PRETAX>                                 17,759
<INCOME-TAX>                                     7,104
<INCOME-CONTINUING>                             10,655
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    10,655
<EPS-PRIMARY>                                      .43
<EPS-DILUTED>                                      .43
<FN>
<F1>Consists of Notes Payable and Bonds Payable
<F2>Consists of Additional Paid-in Capital, Retained Earnings and Foreign Currency
Translation Adjustments
<F3>Consists of Research and Development and Selling, General and Administrative
Expenses
</FN>
        

</TABLE>
Motion Granted; Appeal Dismissed and Memorandum Opinion filed September 6 ,

2012

In The



## Fourteenth Court of Appeals

NO. 14

- 12

- 00732

- CV

AGILE SEISMIC, L

. L

. C

. , Appellant

V.

DYNAMIC GLOBAL ADVIS ORS COMPANY , Appellee

On Appeal from the 125th District Court

Harris County, Texas Trial Court Cause No. 2012

- 27739



### M E M O R A N D U M O P I N I O N

This is an appeal from a judgment signed July 17, 201 2 . On August 22, 201 2, appellant filed a motion to dismiss the appeal because it has been rendered moot. See
Tex. R. App. P. 42.1. The motion is granted.
Accordingly, the appeal is ordered dismissed.

PER CURIAM

Panel consists of Justices Frost, Christopher, and Jamison.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Agency for International Development

# AGENCY:

U.S. Agency for International Development (USAID).

# ACTION:

Notice.

# SUMMARY:

In accordance with the Federal Advisory Committee Act (FACA), the U.S. Agency for International Development is hereby giving notice that the Advisory Committee on Voluntary Foreign Aid (ACVFA) is being re-established.

# ADDRESSES:

                        To view additional information related to ACVFA please visit                         *http://www.usaid.gov/​who-we-are/​organization/​advisory-committee.*

# FOR FURTHER INFORMATION CONTACT:

                        Karen Vargas, Designated Federal Officer for ACVFA, at                         *kvargas@usaid.gov*                         or 202-705-5769.                    

# SUPPLEMENTARY INFORMATION:

ACVFA brings together USAID and representatives from private voluntary organizations (PVO), universities, nongovernmental organizations (NGOs), and multilateral and private organizations to foster understanding, communication, and cooperation in the area of foreign aid. The Administrator of USAID is re-establishing the committee for two years, effective on the date of filing of its renewed charter.

Karen Vargas,

ACVFA Designated Federal Officer.

[FR Doc. 2024-20178 Filed 9-6-24; 8:45 am]

BILLING CODE 6116-01-P
EXHIBIT 31.2

Certification of Chief Financial Officer pursuant to Rules 13a-14(a) and 15d-14(a) promulgated under the Securities Exchange Act of 1934, as  amended

CERTIFICATION

I,
Matthew M. Loar, certify that:

1.     I
have reviewed this annual report on Form 10-K of Genelabs Technologies, Inc.;

2.     Based
on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in
light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.     Based
on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition,
results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.     The
registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act
Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f))
for the registrant and we have:



5.     The
registrant's other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's
auditors and the audit committee of registrant's board of directors (or persons performing the equivalent function):



|Date: March 11, 2005 |  | /s/MATTHEW M. LOARMatthew M. Loar
Chief Financial Officer
|-------------------- |  | ---------------------------------------------------------

---



QuickLinks
#### TEXAS STATE LIFE INS. CO. v. PRICE.

No. 2244.

Court of Civil Appeals of Texas. Waco.

Sept. 14, 1939.

O. M. Street, of Dallas, for plaintiff in error.

Plancock & Hancock, of Waxahachie, for defendant in error.

ALEXANDER, Justice.

This case is before the court on motion of defendant in error to affirm on certificate because of the failure of plaintiff in error to file the transcript within the time provided by law. The record discloses that the trial court rendered final judgment on November 7, 1938. Petition for writ of error was filed on March 13, 1939' and service was had thereon on March 15, 1939. The time within which the transcript should have been filed in the Court of Civil Appeals expired May 14, 1939. R.S. art. 1839, as amended 1931, Vernon’s Ann.Civ. St. art. 1839. Defendant in error filed its motion to affirm on certificate August 8, 1939, during the term to which plaintiff in error’s appeal was returnable.

Under the provisions of R.S. art. 1831, Vernon’s Ann.Civ.St. art. 1831, the defendant in error is entitled to have the judgment of the trial court affirmed. Art. 1841, R. S.; 3 Tex.Jur. 737; Beaver v. Beaver, Tex. Civ.App., 57 S.W.2d 279, and authorities there cited.

The motion to affirm on certificate is granted and the judgment of the trial court affirmed.
### D ISTRICT 

### C OURT 

### O F 

### APPEAL 

### O F 

### F LORIDA 

### S ECOND 

### D ISTRICT

LEROY HARDEN, Appellant, v. STATE OF FLORIDA, Appellee. No. 2D23-2085 December 6, 2023 Appeal pursuant to Fla. R. App. P. 9.141(b)(2) from the Circuit Court for Hillsborough County; Michael S. Williams, Judge. PER CURIAM. Affirmed. CASANUEVA, SMITH, and LABRIT, JJ., Concur. Opinion subject to revision prior to official publication.
EXHIBIT 32.2

     CERTIFICATION  PURSUANT TO 18 U.S.C.  SECTION  1350 AS ADOPTED  PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

         In connection with the Quarterly Report of EP MedSystems, Inc. (the
"Company") on Form 10-QSB for the period ended March 31, 2004 as filed with the
Securities and Exchange Commission (the "Report"), each of the undersigned, in
the capacities and on the dates indicated below, hereby certifies pursuant to 18
U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that:

          1. The Report fully complies with the requirements of Section 13(a) or
     15(d) of the Securities Exchange Act of 1934; and

          2. The  information  contained in the Report fairly  presents,  in all
     material respects,  the financial condition and results of operation of the
     Company


Date:  May 12, 2004               /s/ Matthew C. Hill
                                  -------------------------------
                                  Matthew C. Hill
                                  Chief Financial Officer
                                  (Principal Financial Officer)
##### 



EXHIBIT 32.1
 CERTIFICATION
  1.
    
    The Companys Quarterly Report on Form 10-Q for the period ended March 31, 2006, to which
this Certification is attached as Exhibit 32.1 (the Periodic Report), fully complies with
the requirements of Section 13(a) or Section 15(d) of the Exchange Act; and
 2.
    
    The information contained in the Periodic Report fairly presents, in all material respects,
the financial condition of the Company at the end of the period covered by the Periodic Report
and results of operations of the Company for the period covered by the Periodic Report.
  /s/ Hollings C. RentonHollings C. RentonChairman of the Board, President
and Chief Executive Officer
(Principal Executive Officer) /s/ Gregory W. SchaferGregory W. SchaferVice President and Chief Financial Officer
(Principal Financial Officer) 
 A signed original of this written statement required by Rule 13(a)-14(b) of the Exchange Act
and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. § 1350) has been
provided to Onyx Pharmaceuticals, Inc. and will be retained by Onyx Pharmaceuticals, Inc. and
furnished to the Securities and Exchange Commission or its staff upon request.This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the
Securities and Exchange Commission and is not to be incorporated by reference into any filing of
Onyx Pharmaceuticals, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange
Act of 1934, as amended (whether made before or after the date of the Form 10-Q), irrespective of
any general incorporation language contained in such filing. 43
August 15, 2015

Joseph Horton

4700 Parrau Drive

Columbus, OH 43228

Tel: (6140285-9495

Horton.Joe@icloud.com

Dear Sirs,

I am writing to file a petition for an exemption under section 333. 

I would like to use a UAS for the purposes of Aerial Photography, Videography 

and Real Estate Photography. 

Aircraft –

3DR Solo Smart Drone Aircraft- Cameras: Compatible with GoPro® HERO3, 

3+ and 4; optimized for HERO3+ and 4 

Streaming video quality: 720p 

Flight time: 25 minutes; 20 minutes with payload* 

Range: .5 miles** (.8 km) 

Max speed: 55 mph (89 km/h) 

Max ascent speed: 10 m/s in stabilize mode; “fly” mode spec forthcoming 

Max descent speed: ditto 

Max payload: 420 g 

Max altitude: 400 ft per FAA regulation, user adjustable (122 m) 

Motors: 880 kV 
Propellers: 10ʺ′′ diameter 4.5ʺ′′ pitch self-tightening (24 cm diameter 144 cm 

pitch) 

Autopilot: Pixhawk 2 

Software: APM: Copter 

Communication: 3DR Link secure WiFi network 

Frequency: 2.4 GHz 

Weight: 3.3 lbs. (1.5 kg) / 3.9 lbs. (1.8 kg) with GoPro® and Solo Gimbal 

Dimensions: 10 in. tall (25 cm), 18 in. (46 cm) motor-to-motor Flight battery: 

Lithium polymer 5200 mAh 14.8 Vdc 

Battery charge time: ~1.5 hoursController battery: 2600 mAh 7.2 Vdc 

rechargeable lithium ion 

Payload – GoPro4 Camera on Gimbal mount, Wi-Fi operating on 2.4 GHz. 

Operation – As is the case with any Aircraft, I will conduct a pre-flight procedure. 

Regarding the Solo - before takeoff the Aircraft must be inspected to ensure that 

it is in airworthy condition. The radio control transmitter must be set up correctly, 

all switches correctly configured. The aircraft must obtain a reliable GPS lock to 

ensure correct operation of in-flight stabilization and ‘Return Home’ function in 

event of transmitter malfunction. 

Flights will only be conducted in calm and fine weather conditions.

Operation will be avoided if there are too many obstacles in the area.

Most photography will be executed from an altitude of less than 80 ft. AGL.

Occasional operation to maximum allowed altitude of 400 ft. AGL, mainly for 

large agricultural or commercial properties.
Maximum speed not in excess of 5 knots, most photography is conducted using 

a walk behind the aircraft method and then adjusting Altitude and Lateral location 

to achieve the desired Photograph. 

I agree to abide by FAA rules regarding Airport proximity and designated no-fly 

zones.

All operations will be conducted in a safe manner; any persons on the property 

will be indoors or behind operator location. 

Operations will only be conducted with permission from property owners. 

Thank you for your consideration. Regards. 

Joseph Horton
August 12, 2010








James E. Hohmann, CEO


FBL Financial Group, Inc.


5400 University Avenue


West Des Moines, IA 50266





Re:    Forbearance Agreement/Dividend Reduction





Dear Jim:





You will recall we executed a Forbearance Agreement effective until August 31, 2010 in regard to the royalty agreement between the Iowa Farm Bureau Federation ("IFBF") and the insurance companies that are managed by FBL using the Farm Bureau name, Farm Bureau Property & Casualty Insurance Company and Farm Bureau Life Insurance Company (hereinafter "Insurance Companies"). Paragraph 9(d) of the royalty agreement states that a reduction in the quarterly dividend by FBL below $.10 per quarter creates a power of termination of the agreement on the part of IFBF.





Upon your request, and after reviewing the current situation, IFBF is willing to extend the term of the Forbearance Agreement and thereby continue to forego IFBF's right of termination through March 31, 2010. This continued forbearance is conditioned upon:





1.   No reduction in the quarterly dividend below $0.0625 per share through March 31, 2011; and


2.   An acknowledgment on behalf of the Insurance Companies that IFBF is waiving no rights or claims under the royalty agreement by this continued forbearance.





If you wish to accept the terms of this offer of continued forbearance on behalf of the Insurance Companies, please acknowledge the same by signing below.





Sincerely yours,





/s/ CRAIG A. LANG





Craig Lang


President, Iowa Farm Bureau Federation








Acceptance:





The undersigned, as CEO of FBL Financial Group, Inc., Farm Bureau Life Insurance Company and Farm Bureau Property & Casualty Insurance Company, does acknowledge agreement to the terms of the forbearance set forth above.





/S/ JAMES E. HOHMANN


____________________________________


James E. Hohmann, CEO
```

[Congressional Bills 111th Congress]
[From the U.S. Government Publishing Office]
[H.R. 117 Introduced in House (IH)]

111th CONGRESS
  1st Session
                                H. R. 117

  To prohibit a State from imposing a discriminatory commuter tax on 
                 nonresidents, and for other purposes.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            January 6, 2009

Mr. Frelinghuysen introduced the following bill; which was referred to 
                     the Committee on the Judiciary

_______________________________________________________________________

                                 A BILL

 
  To prohibit a State from imposing a discriminatory commuter tax on 
                 nonresidents, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. PROHIBITION ON IMPOSING DISCRIMINATORY COMMUTER TAX ON 
              NONRESIDENTS.

    (a) Prohibition.--A State may not impose a tax on the income earned 
in the State by nonresidents unless the tax is of substantial equality 
of treatment for the citizens of the State and the nonresidents so 
commuting.
    (b) State.--For purposes of subsection (a), the term ``State'' 
includes the District of Columbia and any political subdivision of a 
State.
                                 <all>
```
CERTIFICATIONS

                             Certificate Pursuant to

18 U.S.C. Section 1350, as Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly  Report of Phlo  Corporation  and  Subsidiaries
(the  "Company")  the Company on Form 10-QSB for the quarter ended June 30, 2003
as filed with the  Securities  and Exchange  Commission  on the date hereof (the
"Report"), I, James B. Hovis, Chief Executive Officer,  certify,  pursuant to 18
U.S.C. 1350, as adopted pursuant to 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and

(2) The  information  contained in the Report fairly  presents,  in all material
respects, the financial condition and results of operations of the Company.

Date: April 15, 2005

                                 /s/ James B. Hovis
                                 ---------------------------
                                 James B. Hovis
                                 Chief Executive Officer
                                 Principal Financial Officer
[Federal Register Volume 65, Number 28 (Thursday, February 10, 2000)]
[Notices]
[Page 6638]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-3095]


=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION

[Docket No. 50-255]


Consumers Energy Company; Notice of Withdrawal of Application for 
Amendment to Facility Operating License

    The U.S. Nuclear Regulatory Commission (the Commission) has granted 
the request of Consumers Energy Company (the licensee) to withdraw its 
November 9, 1998, application for proposed amendment to Facility 
Operating License No. DPR-20 for the Palisades Plant, located in 
Covert, Michigan.
    The proposed amendment would have revised the Technical 
Specifications by deleting the chemical and volume control system 
(CVCS) operability and surveillance requirements, which the licensee 
had incorporated into the facility's Operating Requirements Manual 
(ORM). In its letter of January 13, 2000, the licensee stated that the 
proposed amendment was no longer needed because (1) the CVCS repairs 
anticipated at the time of the application for amendment were completed 
during a subsequent forced outage, and (2) the NRC's subsequent 
approval of the Improved Technical Specifications (Amendment 189, dated 
November 30, 1999) deleted the CVCS requirements that the licensee had 
incorporated into the ORM.
    The Commission had previously issued a Notice of Consideration of 
Issuance of Amendment published in the Federal Register on December 16, 
1998 (63 FR 69337). However, by letter dated January 13, 2000, the 
licensee withdrew the proposed change.
    For further details with respect to this action, see the 
application for amendment dated November 9, 1998, and the licensee's 
letter dated January 13, 2000, which withdrew the application for 
license amendment. The above documents are available for public 
inspection at the Commission's Public Document Room, the Gelman 
Building, 2120 L Street, NW., Washington, DC, and accessible 
electronically through the ADAMS Public Electronic Reading Room link at 
the NRC Web site (http://www.nrc.gov).

    Dated at Rockville, Maryland, this 2d day of February 2000.

    For the Nuclear Regulatory Commission.
Darl S. Hood,
Senior Project Manager, Section1, Project Directorate III, Division of 
Licensing Project Management, Office of Nuclear Reactor Regulation.
[FR Doc. 00-3095 Filed 2-9-00; 8:45 am]
BILLING CODE 7590-01-P
By Notice dated October 8, 1999, and published in the                     **Federal Register**                     on October 18, 1999, (64 FR 56225), Cedarburg Laboratories, Inc., 870 Badger Circle, Grafton, Wisconsin 53024, made application by letter to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of propiram (9649), a basic class of controlled substance listed in Schedule I.                

The firm will manufacture propiram in the process of manufacturing other targeted test compounds for another firm.

DEA has considered the factors in Title 21, United States Code, Section 823(a) and determined that the registration of Cedarburg Laboratories, Inc. to manufacture propiram is consistent with the public interest at this time. DEA has investigated the company to ensure that the company's registration is coninspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy Assistant Administrator, Office of Diversion Control, hereby orders that the application submitted by the above firm for registration as a bulk manufacturer of the basic class of controlled substance listed above is granted.

Dated: February 4, 2000.

John H. King,

Deputy, Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

[FR Doc. 00-3142  Filed 2-9-00; 8:45 am]

BILLING CODE 4410-09-M